GoodRx Holdings, Inc.

GoodRx Holdings, Inc. is an American healthcare company that operates a telemedicine platform and a free-to-use website and mobile application. Its core business involves tracking prescription drug prices across more than 75,000 pharmacies in the United States and providing coupons for significant discounts on medications. The company's mission is to help Americans access the healthcare they need at an affordable price, aiming to build better ways for individuals to find the right care at the best cost. GoodRx is headquartered in Santa Monica, California.

Key offerings include prescription drug price comparison tools, discount coupons, and a subscription service called GoodRx Gold, which provides deeper savings. The company also provides telehealth services through GoodRx Care, enabling online consultations with licensed healthcare providers for various conditions and prescription needs. GoodRx has expanded its services to include condition-specific subscription plans and facilitates access to GLP-1 medications, such as semaglutide (Ozempic, Wegovy), through its platform and partnerships with pharmaceutical manufacturers.

Wendy Barnes was appointed President and CEO of GoodRx, effective January 1, 2025, bringing extensive experience from the pharmacy and medical benefit industry. Co-founders Trevor Bezdek and Doug Hirsch remain involved as board members. In recent news, GoodRx announced in May 2026 that it expanded its offerings to include access to the Ozempic® pill (oral semaglutide) for Type 2 Diabetes patients, providing discounted self-pay pricing. The company reported fourth-quarter 2025 revenues that exceeded analyst estimates, though its full-year 2026 revenue guidance was below forecasts. GoodRx is positioned as a leading platform for medication savings, connecting various stakeholders within the healthcare ecosystem.